Determination of sub-nanogram amounts of dihydroergotamine in plasma and urine using liquid chromatography and fluorimetric detection with off-line and on-line solid-phase drug enrichment

This publication has 11 references indexed in Scilit:

• HPLC Method for Determination of Ergot Alkaloids and Some Derivatives in Human Plasma
  Human Toxicology, 1985
• Doxorubicin decomposition on storage. Effect of pH, type of buffer and liposome encapsulation
  International Journal of Pharmaceutics, 1985
• Immunoassay of ergotamine and dihydroergotamine using a common 3H-labelled ligand as tracer for specific antibody and means to overcome experienced pitfalls
  International Journal of Nuclear Medicine and Biology, 1984
• Elucidation of the structure and receptor binding studies of the major primary, metabolite of dihydroergotamine in man
  European Journal of Clinical Pharmacology, 1984
• Determination of dihydroergocristine and dihydroergotamine in plasma by high-performance liquid chromatography with fluorescence detection
  Journal of Chromatography B: Biomedical Sciences and Applications, 1983
• Bioavailability of dihydroergotamine in man.
  British Journal of Clinical Pharmacology, 1982
• Low oral bioavailability of dihydroergotamine and first-pass extraction in patients with Orthostatic hypotension
  Clinical Pharmacology & Therapeutics, 1981
• Application of column switching in high-performance liquid chromatography to on-line sample preparation for complex separations
  Journal of Chromatography A, 1981
• Quantitative determination of ergot alkaloids in biological fluids by radioimmunoassay.
  British Journal of Clinical Pharmacology, 1978
• 9,10-Dihydroergotamine: Production of antibodies and radioimmunoassay
  Cellular and Molecular Life Sciences, 1976